GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (OTCPK:GLAXF) » Definitions » Common Stock

GSK (GLAXF) Common Stock : $1,704 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is GSK Common Stock?

GSK's quarterly common stock increased from Jun. 2024 ($1,715 Mil) to Sep. 2024 ($1,783 Mil) but then declined from Sep. 2024 ($1,783 Mil) to Dec. 2024 ($1,704 Mil).

GSK's annual common stock increased from Dec. 2022 ($1,641 Mil) to Dec. 2023 ($1,706 Mil) but then declined from Dec. 2023 ($1,706 Mil) to Dec. 2024 ($1,704 Mil).


GSK Common Stock Historical Data

The historical data trend for GSK's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Common Stock Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,809.14 1,791.22 1,640.68 1,706.33 1,704.17

GSK Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,706.33 1,712.83 1,715.01 1,783.07 1,704.17

GSK Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


GSK Business Description

Address
79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.